National Consultant to Document the Economic Burden of AMR in Pakistan

Job title: National Consultant to Document the Economic Burden of AMR in Pakistan

Company:


Job description: INTRODUCTIONThe Fleming Fund (FF) is a U.K. Department of Health and Social Care programme to help low and middle-income countries fight Antimicrobial Resistance (AMR). AMR poses a severe global threat, expected to cause 10 million deaths annually by 2050. With potential costs reaching $100 trillion, its impact on the global economy is significant. Fleming Fund Grants aim to tackle the AMR challenge in developing countries including Pakistan. The grants are funded by the UK Department of Health and Social Care and managed by Mott MacDonald for the country, regional and fellowship grants. Pakistan has received Fleming Fund support since 2019 in the form of two Country Grants, 9 Fellowships, and central and local procurement of equipment, reagents, and consumables. Between 2017 and the end of phase-1 of the program in March 2023, the program has provided financial support to grantees to establish and support local development of national AMR surveillance systems.In partnership with the Fleming Fund, DAI’s programme in Pakistan collaborates with the Pakistani government to strengthen systems using a “One Health” (OH) approach – a multisectoral approach to complex health problems that reaches across human health, animal health, and environment sectors. As global leaders in One Health, the DAI team helps incorporate One Health across programme interventions. DAI is helping Pakistan become a leader in combating antimicrobial resistance, and a model for better management of antimicrobials in human and animal populations. DAI and its consortium partners have successfully secured an additional round, Phase 2, of the Fleming Fund Country Grant in Pakistan which spans from January 2024 to December 2025. The Phase 2 of the FFCG programme focuses on achieving four intermediate outcomes: 1) Production of quality AMR/U/C and burden of disease data; 2) Conducting quality data analysis; 3) Sharing quality data analysis with decision-makers; and 4) Contributing to sustainable investments at both the country and global levels to counter AMR.Position SummaryUnder the overall supervision of the Sr. Manager Governance & Advocacy (OH), the National Consultant will document the Economic Burden of AMR in Pakistan. The overall purpose of documenting the Economic burden of AMR in Pakistan is to undertake policy advocacy with the political and bureaucratic leadership for better understanding the gravity of the situation, and to encourage the government and development partners to invest in sustainable solutions. The study shall provide the foundation for initiating a dialogue with the political and bureaucratic leadership over a strong evidence base.Key Objectives:1. Data Review & Baseline Assessment:

• Conduct a comprehensive literature review to collate data on AMR prevalence and antimicrobial usage trends in Pakistan.
• Assess existing healthcare utilization data from sources such as the Pakistan Demographic and Health Survey (PDHS 2018-19), DHIS, National Health Accounts (2021), and AMR surveillance reports of NIH and allied projects.
• Assess the and government AMR related budgetary allocations and expenditure trends at National and Sub-national levels.
• Assess the Private Health Sector Costs vis-a-vis AMR and related antimicrobial use patterns.
• Assess the donor and partners contribution through AMR containment related initiatives, including technical support parameters.
• Assess the costs incurred on Out of Packet expenditures of Households due to AMR and its consequences on Households.

2. Economic Cost Analysis:

• Estimate direct costs, including diagnostic tests, treatments, prolonged hospital stays, and healthcare system expenses due to AMR.
• Calculate indirect costs, such as productivity losses, absenteeism, and premature deaths using established economic frameworks like the Cost-of-Illness (COI) model.
• Estimate the Household out-of-pocket expenditures (OOP) due to AMR such as and use of more expensive antimicrobials, hospital stays etc.

3. Stakeholder Engagement:

• Conduct consultations with stakeholders, including public health officials, healthcare providers, pharmaceutical industry representatives, and development partners, to validate data and gather qualitative insights.

4. Policy Gap Analysis:

• Identify economic and policy gaps in the current AMR response.
• Highlight areas requiring immediate attention for cost-effective interventions.

5. Final Reporting:

• Develop a detailed report with findings, conclusions, and recommendations.
• Provide a policy brief summarizing key insights for decision-makers.

Requirements (Education, Experience, Skills, Languages etc.):

• The ideal candidate for this position must hold a Master or higher degree in public health, health statistics, health economics, or other relevant fields.
• A minimum of 10 years of experience in Public Financial Management.
• He/she should demonstrate a robust track record of data collection, analysis and evidence use, particularly within the public health sector.
• The candidate is expected to possess a deep understanding of the One Health sector in Pakistan, including familiarity with challenges related to limited data availability and insufficient data and evidence use across key departments. The individual should showcase proven expertise in facilitating participatory approaches and effectively engaging diverse stakeholders within both public and private sectors.
• Excellent written, editing, and oral communication skills in English are imperative. Preference will be given to candidates with prior experience working on FCDO programmes.

Expected salary:

Location: Islamabad

Job date: Wed, 15 Jan 2025 05:16:52 GMT

To help us track our recruitment effort, please indicate in your email/cover letter where (jobsnear.pro) you saw this job posting.Thanks&Good Luck